In 30–50% of cases of BWS, expression of CDKN1C decreases due to DNA hypomethylation, while expression of IGF2 increases due to DNA hypermethylation of the IGF2/H19 domain (9). This evidence concerns the gene IGF2 and Beckwith-Wiedemann syndrome.